Evidence map›Paper›PMID 28765611›Full record

ArticleScientific reports2017

The differentiation of ROR-γt expressing iNKT17 cells is orchestrated by Runx1.

Puspa Thapa, Bryce Manso, Ji Young Chung, Sinibaldo Romera Arocha, Hai-Hui Xue, Derek B Sant' Angelo, Virginia Smith Shapiro

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Markers and makers of NKT17 cells.Experimental & molecular medicine · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Differential Control ofFrontiers in immunology · 2019
    Article
  16. Article
  17. IL-17 in neonatal health and disease.American journal of reproductive immunology (New York, N.Y. : 1989) · 2018
    Review
  18. Review
  19. Unraveling Natural Killer T-Cells Development.Frontiers in immunology · 2017
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Puspa ThapaDepartment of Immunology, Mayo Clinic, College of Medicine, 200 1st Street SW, Rochester, MN, 55905, USA.
Bryce MansoDepartment of Immunology, Mayo Clinic, College of Medicine, 200 1st Street SW, Rochester, MN, 55905, USA.
Ji Young ChungDepartment of Immunology, Mayo Clinic, College of Medicine, 200 1st Street SW, Rochester, MN, 55905, USA.
Sinibaldo Romera ArochaDepartment of Immunology, Mayo Clinic, College of Medicine, 200 1st Street SW, Rochester, MN, 55905, USA.
Hai-Hui XueDepartment of Microbiology and Immunology, University of Iowa, 51 Newton Rd Iowa City, IA, 52242, USA.
Derek B Sant' AngeloDepartment of Pediatrics, Rutgers Robert Wood Johnson Medical School and The Children's Health Institute of New Jersey, 89 French Street, New Brunswick, NJ, 08901, USA.
Virginia Smith ShapiroDepartment of Immunology, Mayo Clinic, College of Medicine, 200 1st Street SW, Rochester, MN, 55905, USA. shapiro.virginia1@mayo.edu.
Mayo Clinic · USRutgers, The State University of New Jersey · USUniversity of Iowa · US

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Christopher K Laubenthal · 2000 to 2026
$70.0M
Tcf/Lef and B-catenin pathway in follicular helper T cellsR01AI121080 · NIAID · UNIVERSITY OF IOWA · PI Hai-Hui Xue · 2016 to 2026
$4.6M
Regulation of T cell maturationR01AI083279 · NIAID · MAYO CLINIC ROCHESTER · PI SHAPIRO, VIRGINIA SMITH · 2010 to 2019
$3.8M
NIAID NIH HHS R01 AI083279NIAID NIH HHS R01 AI121080
6 · The paper itself

Abstract

iNKT cells are a unique lineage of T cells that recognize glycolipid presented by CD1d. In the thymus, they differentiate into iNKT1, iNKT2 and iNKT17 effector subsets, characterized by preferential expression of Tbet, Gata3 and ROR-γt and production of IFN-γ, IL-4 and IL-17, respectively. We demonstrate that the transcriptional regulator Runx1 is essential for the generation of ROR-γt expressing iNKT17 cells. PLZF-cre Runx1 cKO mice lack iNKT17 cells in the thymus, spleen and liver. Runx1-deficient iNKT cells have altered expression of several genes important for iNKT17 differentiation, including decreased expression of IL-7Rα, BATF and c-Maf and increased expression of Bcl11b and Lef1. However, reduction of Lef1 expression or introduction of an IL-7Rα transgene is not sufficient to correct the defect in iNKT17 differentiation, demonstrating that Runx1 is a key regulator of several genes required for iNKT17 differentiation. Loss of Runx1 leads to a severe decrease in iNKT cell numbers in the thymus, spleen and liver. The decrease in cell number is due to a combined decrease in proliferation at Stage 1 during thymic development and increased apoptosis. Thus, we describe a novel role of Runx1 in iNKT cell development and differentiation, particularly in orchestrating iNKT17 differentiation.

Indexed as

Cell DifferentiationAnimalsCore Binding Factor Alpha 2 SubunitLiverMiceMice, KnockoutNatural Killer T-CellsNuclear Receptor Subfamily 1, Group F, Member 3SpleenThymus GlandT-Lymphocyte SubsetsCore Binding Factor Alpha 2 SubunitNuclear Receptor Subfamily 1, Group F, Member 3Runx1 protein, mouse

Identifiers

PMID28765611
PMCPMC5539328
OpenAlexW2739390984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.